-
Study aim
-
Evaluation of the effect of Atrilal plant on vitiligo
-
Design
-
Clinical trial with intervention and control groups, with parallel groups, double-blind, randomized, phase 3 on 62 patients. A random table was used for randomization.
-
Settings and conduct
-
This study will be performed as a clinical trial for patients with vitiligo referred to Omid Clinic and Farshchian Hospital in the dermatology ward in 1999. The daily requirement of each person according to the sources of Iranian medicine is two ounces (each ounce is equal to 4.608 grams) of Falcaria Vulgaris egg with the same weight as honey, which should be used for 15-20 days. The same amount of starch and honey will be prepared in containers that look exactly like medicine containers without a label identifying the drug or placebo. Both groups will receive BLIND for 20 days. After one week and after the end of the treatment period, the patients will be examined by a dermatologist and Iranian medicine. Patients will be re-examined one month after the end of the treatment period.
-
Participants/Inclusion and exclusion criteria
-
Clinical diagnosis of vitiligo recently or in case of previous diagnosis of non-drug use from one month ago, normal blood, liver, kidney, anti-nuclear antibodies and eye examination, no use of effective concomitant treatment for vitiligo, no pregnancy, no Having light-sensitive diseases such as lupus and porphyria, not using light-sensitizing drugs such as retinoids and cotrimoxazole
-
Intervention groups
-
Each person is given two ounces (4.608 grams per ounce) of Falcaria Vulgaris egg with the same weight of honey daily to be used for 15-20 days. The same amount of starch and honey will be prepared in containers that look exactly like medicine containers without a label identifying the drug or placebo.
-
Main outcome variables
-
Lack of response to treatment, partial recovery, complete recovery in all lesions